Female Health, Blood, and Immunity

How dong quai's ferulic acid, ligustilide, and polysaccharides support menstrual health, circulation, and immune function

Dong quai — the dried root of Angelica sinensis — is one of the most used herbs in Traditional Chinese Medicine, often called "female ginseng" for its long history supporting menstrual and reproductive health. Its root contains a distinctive trio of active compounds: ferulic acid, the phthalides (especially Z-ligustilide), and immune-active polysaccharides. Research confirms these compounds have anti-inflammatory, smooth muscle-relaxing, and immune-modulating properties [2]. Dong quai is typically used in formula with other herbs in TCM practice, and its effects — while well-studied in Chinese pharmacology — are more modest when used in isolation [3].

Active Compounds and What They Do

The medicinal properties of dong quai trace to three main chemical families in its root [2]:

Ferulic acid is a polyphenol found in many plants, but dong quai root concentrates it in pharmacologically relevant amounts. Ferulic acid inhibits NF-κB, a central switch in the inflammatory response, and suppresses the release of prostaglandins and thromboxane — the compounds behind menstrual cramping and blood clotting. It also relaxes smooth muscle in blood vessel walls, which supports circulation and reduces blood pressure in animal models.

Phthalides — primarily Z-ligustilide and n-butylidenephthalide — give dong quai its characteristic celery-like smell. Z-ligustilide relaxes uterine smooth muscle, which may explain the herb's traditional use for menstrual cramps. It also shows anti-inflammatory effects by inhibiting the COX-2 enzyme pathway (similar to ibuprofen's mechanism, though far less potent) and has demonstrated neuroprotective effects in cell studies.

Polysaccharides — long-chain sugars in the root — activate immune cells, including macrophages and T lymphocytes, and boost cytokine production (IL-2, IFN-gamma). This makes them of interest for immune support, separate from the herb's hormonal reputation [4].

Traditional Use Context

In TCM, dong quai is prescribed for "blood deficiency" — a pattern that broadly maps to symptoms like fatigue, pale complexion, menstrual irregularity, and poor circulation. It is almost never used alone; instead, it anchors formulas like Danggui Buxue Tang (dong quai with astragalus) or Si Wu Tang (four-substance decoction), where synergy between herbs is considered essential.

This matters for interpreting research. Western trials testing dong quai alone, as a standardized extract against a placebo, are testing a different thing than what traditional practitioners use. Critics of these trials — and there are legitimate ones — note that testing a single herb outside its intended formula is like testing one ingredient from a complex recipe [3].

Menopause and Estrogenic Claims

Dong quai has been widely marketed in the West as a natural estrogen replacement. The evidence does not support this specific claim when the herb is used alone. A 1997 double-blind trial in 71 postmenopausal women found no significant changes in vaginal maturation, endometrial thickness, or hot flash frequency compared to placebo over 24 weeks [1]. The herb's ferulic acid can bind weakly to estrogen receptors, but this does not translate to measurable estrogenic effects in human tissue at typical doses.

Where dong quai may have more genuine value is in combination formulas targeting menstrual pain, perimenopause, and blood circulation — contexts closer to its traditional use.

Dosage and Forms

Dried root decoction: 3–15 g per day, simmered in water as part of a formula
Standardized extract: typically 4.5 g equivalent per day
Tincture: 1:3 or 1:5 extracts; dose per manufacturer guidance
Powdered capsule: 500–2,000 mg per day

Ferulic acid content is the most common standardization marker.

Safety and Interactions

Dong quai contains coumarin derivatives that can potentiate blood-thinning medications. Case reports document significantly elevated INR in patients on warfarin who added dong quai without adjusting their dose. If you take anticoagulants, avoid this herb without medical supervision.

The root contains furanocoumarins that cause photosensitivity — increased sensitivity to UV light. This is relevant for people spending time in the sun.

Because of concerns about cell proliferation in estrogen-receptor-positive cell lines [5], women with hormone-sensitive breast cancer are typically advised to avoid dong quai pending clearer clinical evidence.

Avoid during pregnancy due to uterine-stimulating effects. Safe for short-term use (up to 6 months) in otherwise healthy adults at standard doses.

See our ashwagandha page for another adaptogenic herb used in female hormonal health, or our vitex page for a Western herb with stronger direct evidence for menstrual cycle regulation.

Evidence Review

Clinical Trials: Estrogenic Effects and Menopause

The most cited clinical trial is Hirata et al. (1997, n=71), a 24-week randomized double-blind placebo-controlled study of postmenopausal women [1]. Participants received either dong quai (4.5 g/day standardized extract) or placebo. Primary endpoints were vaginal maturation index, endometrial thickness (measured by ultrasound), and vasomotor symptoms (hot flashes). No statistically significant differences emerged between groups on any endpoint. The study was well-designed and adequately powered for its primary outcome. The authors concluded that dong quai, used alone, does not produce clinically meaningful estrogenic effects and is no more effective than placebo for hot flash relief.

This finding has been replicated in smaller trials. The weight of evidence does not support solo dong quai for vasomotor menopausal symptoms.

However, Hook (2014) provides an important frame for these results [3]. In a comprehensive pharmacological review across 152 studies, she argues that Western trials test standardized extracts at fixed doses, while TCM practitioners select individualized formulas using fresh or properly cured root, adjusted for the patient's specific pattern. The bioavailability of ligustilide and ferulic acid changes substantially with preparation method. Hook concludes that negative Western trials may reflect preparation and context differences more than inherent lack of efficacy.

Bioactive Compound Pharmacology

Chao and Lin (2011) provide the most thorough review of dong quai's constituent bioactivities [2]. Their analysis establishes:

Ferulic acid: Reduces prostaglandin E2 and thromboxane B2 synthesis; inhibits platelet aggregation; relaxes vascular smooth muscle via nitric oxide signaling; anti-tumor activity in several cell lines
Z-ligustilide: Inhibits COX-2 protein expression and PGE2 production; demonstrates antifungal activity; relaxes tracheal and uterine smooth muscle; neuroprotective in focal cerebral ischemia models
n-Butylidenephthalide: Anti-cancer activity against glioblastoma cell lines; anti-inflammatory via NF-κB suppression; anti-platelet aggregation effects

These mechanisms are pharmacologically coherent with the herb's traditional use for menstrual pain, blood stagnation, and circulation — even if clinical trials in defined populations remain limited.

Immune Modulation

Yang et al. (2006) isolated and characterized a polysaccharide fraction from fresh Angelica sinensis root and tested its immunomodulatory effects on murine splenocytes in vitro [4]. Incubation with the Angelica sinensis polysaccharide (AP) significantly promoted proliferation of total spleen cells, macrophages, and T lymphocytes. AP also increased production of IL-2 and IFN-gamma (Th1-type cytokines) while decreasing IL-4 (a Th2-type cytokine), suggesting a shift toward cellular immune activation. These findings are consistent with earlier work on Angelica polysaccharides and are mechanistically plausible for immune-enhancing applications. Human clinical data on immune endpoints remain sparse.

Safety Signal: Hormone-Sensitive Contexts

Lau et al. (2005) examined whether dong quai was appropriate for women with breast cancer seeking menopausal symptom relief [5]. The water extract dose-dependently stimulated proliferation of MCF-7 cells (estrogen receptor-positive breast cancer line) and showed weak agonistic activity in the presence of 17β-estradiol. This was an in vitro study and cannot be directly extrapolated to in vivo risk — concentrations used in cell studies often exceed what circulates after oral dosing. However, given the uncertainty, oncologists and clinical herbalists typically advise against dong quai use in ER-positive breast cancer.

Strength of Evidence Summary

Application	Evidence Level	Notes
Menstrual cramp relief (in formula)	Moderate	Traditional use, mechanistically plausible; RCT data limited to solo use
Hot flash reduction (solo use)	Weak	RCT shows no benefit vs. placebo [1]
Immune modulation	Preliminary	In vitro polysaccharide data; no human trials
Cardiovascular/circulation support	Preliminary	Ferulic acid mechanisms well-characterized; human data limited
Anti-inflammatory	Moderate (mechanism)	COX-2, NF-κB inhibition confirmed in cell studies [2]

Dong quai occupies an unusual space: a very well-studied herb in Chinese pharmacology with a strong safety record across centuries of use, but with clinical trial data that falls short of Western evidence standards for specific indications when used as a single agent. The honest reading is that it likely does something useful in the context of a well-matched formula — but the precision of that "something" remains incompletely characterized.

References

Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trialHirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Fertility and Sterility, 1997. PubMed 9418683 →
Bioactivities of major constituents isolated from Angelica sinensis (Danggui)Chao WW, Lin BF. Chinese Medicine, 2011. PubMed 21851645 →
Danggui to Angelica sinensis root: are potential benefits to European women lost in translation? A reviewHook IL. Journal of Ethnopharmacology, 2014. PubMed 24365638 →
Immunomodulatory activity of polysaccharide isolated from Angelica sinensisYang T, Jia M, Meng J, Wu H, Mei Q. International Journal of Biological Macromolecules, 2006. PubMed 16839602 →
Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?Lau CB, Ho TC, Chan TW, Kim SC. Menopause, 2005. PubMed 16278617 →